Skip to main content
. 2018 Sep 7;6(4):385–390. doi: 10.14218/JCTH.2018.00027

Fig. 3. Prevalence of HBsAg-positive (A) and the SVR rate of P/R treatment between HBsAg-positive and -negative groups (B) in HCV-infected patients.

Fig. 3.

Abbreviations: HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; P/R, pegylated-interferon plus ribavirin; SVR, sustained virologic response.